Description
Description
Olabir – 150 mg
Composition: Olaprib -150 mg
Therapeutic Class: Anti-Neoplastic
Olabir: Globally Proven Anti-Cancer Medicine
Olabir is the doctor’s prescribed treatment for various cancers. It is available worldwide and accepted due to its affordability and high quality.
Aprazer: Committed to Affordable Healthcare
Aprazer Healthcare is the leading oncology medicine manufacturer that develops premium quality anticancer medicines.
WHO-GMP certified, assured therapeutic efficacy and safety.
What is Olabir?
Poly ADP-Ribose Polymerase inhibitor
Olabir is a targeted therapy anticancer drug, widely used to treat cancers caused by genetic mutations (BRCA 1 and 2).
Uses of Olabir
- • Female malignancies – breast cancer, ovarian cancers
- • Cancers of the pancreas
- • Prostate cancer
How does it work?
- • Kills cancer cells
- • Inhibits the DNA-repairing enzyme
- • Inhibits DNA integration
Common Side Effects
- • Tiredness
- • Low blood count
- • Vomiting
- • Breathing problems
- • Muscle pain
- • Dehydration – vomiting, diarrhea
- • Mouth ulcers
- • Heartburn
- • Skin rashes
- • Loss of appetite
Serious Side Effects
- • Bleeding – blood in urine
- • Bone marrow depression
- • Inflammation in the lungs
- • Severe cough, chest pain, fever
- • Acute Myeloid Leukemia
- • Myelodysplastic Syndrome
Contraindications
- • Not to be used if any previous allergy or hypersensitivity to Olaprib or any excipients
- • Breastfeeding mothers
- • Pregnant women
Precautions
Cautiously to be used in patients with:
- • Anemia
- • Kidney disorders
- • Liver disorders
- • Leukemia
- • Blood disorders
- • History of bone marrow suppression
Warning
- • To be used under medical prescription only
Important Safety and Monitoring Information
Regular monitoring of the:
- • Liver function – elevated liver enzymes
- • Blood count- CBC count
- • Respiratory functions
- • Cardiac functions- heartbeats, atrial flutter
- • Bone density – minerals in the bone
Download Product PDF Attachment
Related products
